×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRDF – cardiff oncology, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRDF
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
08:02 pm
crdf
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting [Yahoo! Finance]
Low
Report
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting [Yahoo! Finance]
4/17
04:01 pm
crdf
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
Low
Report
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
4/9
04:16 pm
crdf
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth [Yahoo! Finance]
Medium
Report
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth [Yahoo! Finance]
4/9
04:01 pm
crdf
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
Medium
Report
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
3/20
07:22 am
crdf
Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer [Yahoo! Finance]
Low
Report
Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer [Yahoo! Finance]
3/19
07:00 am
crdf
Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting
Low
Report
Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting
3/4
02:31 am
crdf
Cardiff Oncology (CRDF) was upgraded by Wall Street Zen from "sell" t
Medium
Report
Cardiff Oncology (CRDF) was upgraded by Wall Street Zen from "sell" t
2/26
04:22 pm
crdf
Cardiff Oncology to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Cardiff Oncology to Participate in Three Upcoming Investor Conferences [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
08:08 pm
crdf
Form 3 Cardiff Oncology, Inc. For: Apr 06 Filed by: Muntner Joshua B
Medium
Report
Form 3 Cardiff Oncology, Inc. For: Apr 06 Filed by: Muntner Joshua B
4/16
08:07 pm
crdf
Form 4/A Cardiff Oncology, Inc. For: Apr 06 Filed by: Muntner Joshua B
Medium
Report
Form 4/A Cardiff Oncology, Inc. For: Apr 06 Filed by: Muntner Joshua B
4/16
04:03 pm
crdf
Form 4 Cardiff Oncology, Inc. For: Apr 14 Filed by: Smeal Tod
Medium
Report
Form 4 Cardiff Oncology, Inc. For: Apr 14 Filed by: Smeal Tod
4/16
04:01 pm
crdf
Form 4 Cardiff Oncology, Inc. For: Apr 06 Filed by: Muntner Joshua B
Medium
Report
Form 4 Cardiff Oncology, Inc. For: Apr 06 Filed by: Muntner Joshua B
4/9
04:10 pm
crdf
Form 8-K Cardiff Oncology, Inc. For: Apr 06
Medium
Report
Form 8-K Cardiff Oncology, Inc. For: Apr 06
4/2
04:17 pm
crdf
Form 4 Cardiff Oncology, Inc. For: Mar 31 Filed by: Mohindru Mani
Low
Report
Form 4 Cardiff Oncology, Inc. For: Mar 31 Filed by: Mohindru Mani
4/2
04:16 pm
crdf
Form 8-K Cardiff Oncology, Inc. For: Mar 27
Neutral
Report
Form 8-K Cardiff Oncology, Inc. For: Mar 27
3/26
04:42 pm
crdf
Form SCHEDULE 13G/A Cardiff Oncology, Inc. Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A Cardiff Oncology, Inc. Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: